Bulletin
Investor Alert

London Markets Open in:

Market Pulse Archives

Sept. 21, 2020, 2:31 p.m. EDT

Graybug Vision looks to raise up to $80 million as IPO terms set

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Graybug Vision Inc. (GRAY)
  • X
    Renaissance IPO ETF (IPO)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Graybug Vision Inc. /zigman2/quotes/207596700/composite GRAY -3.43% set terms of its initial public offering, in which the California-based biopharmaceutical company focused on retina and optic never disease treatments looks to raise $79.7 million. The company is offering 4.79 million shares in the IPO, which is expected to price between $15 and $17 a share. With 19.16 million shares outstanding after the IPO, the expected pricing would value the company at up to $325.6 million. The stock is expected to list on the Nasdaq under the ticker symbol "GRAY." SVB Leerink and Piper Sandler are the lead underwrites. For the six months ended June 30, the company recorded a net loss of $18.5 million on no revenue, after a loss of $19.1 million on no revenue in the same period a year ago. The company is looking to go public at a time that the Renaissance IPO ETF /zigman2/quotes/207665280/composite IPO -2.45% has gained 21.0% over the past three months while the S&P 500 /zigman2/quotes/210599714/realtime SPX -0.22% has edged up 4.7%.

/zigman2/quotes/207596700/composite
US : U.S.: Nasdaq
$ 15.75
-0.56 -3.43%
Volume: 78,499
Oct. 21, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$327.72 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/207665280/composite
US : U.S.: NYSE Arca
$ 54.10
-1.36 -2.45%
Volume: 462,731
Oct. 21, 2020 4:00p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,435.56
-7.56 -0.22%
Volume: 2.07B
Oct. 21, 2020 5:09p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.